Abstract
Objective: COVID-19 infection results in a hypercoagulable state predisposing patients to thrombotic events. We report the 3- and 6-month follow-up of 27 patients who experienced acute arterial thrombotic events in the setting of COVID-19 infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have